正瀚-創 News Releases

Cheng Han-Chuang Announces Completion and Execution Results of Second Treasury Stock Buyback Program

Cheng Han-Chuang announces the conclusion of its second treasury stock buyback program. A total of 1… · 2026-08-15

【Cheng Han-Chuang】Part of Our Information Systems Subjected to Hacker Cyberattack

Cheng Han-Chuang confirms that part of its information systems was targeted by a cyberattack. The co… · 2026-08-11

Zhenghan-Chuang Announces Board Approval of Consolidated Financial Report for Q2 2026

Zhenghan-Chuang announced that its board of directors has approved the consolidated financial report… · 2026-07-24

Cheng Han Biotech Announces Appointment of New Financial Officer and Corporate Governance Officer

Cheng Han Biotech has announced a personnel change in its financial and corporate governance leaders… · 2026-07-24

【Cheng Han-Chuang】Announcement of Change in Chief Executive Officer

Cheng Han-Chuang announced a change in its CEO effective July 24, 2026. Mr. Chen Wen-Ren has been re… · 2026-07-24

Zheng Han-Chuang Announces Board Resolution on Dividend Distribution

Zheng Han-Chuang's board has resolved to distribute cash dividends for the first half of 2026, amoun… · 2026-07-24

【Cheng Han-Chuang】Announcement of Change in Chief Executive Officer (Correction of Effective Date)

Cheng Han-Chuang announced the change in its General Manager. Dr. Yang Chun-Yi will assume the role … · 2026-07-24

【Cheng Han-Chuang】Company Invited to Participate in the 2026 Taiwan VC & Private Equity Investment Annual Conference - TWSE Session Corporate Presentation

Cheng Han-Chuang has been invited to attend the corporate presentation session at the 2026 Taiwan VC… · 2026-07-08

Cheng Han-Chuang Announces Board Resolution for Second Treasury Stock Buyback

Cheng Han-Chuang's board has resolved to conduct a second buyback of up to 2 million shares, represe… · 2026-06-16

[AppliedChem-CREATE] February 2026 Revenue: NT$273 Million (YoY +2.1%)

AppliedChem-CREATE released its revenue report for February 2026, recording NT$273 million, a 2.1% i… · 2026-02-01

Zhenghan-Chuang Reports May 2026 Revenue of NT$141 Million (Up +7.3% Year-on-Year)

Zhenghan-Chuang announced its revenue for May 2026 reached NT$141 million (NT$141,363 thousand), rep… · 2026-05-01

[CHENG HANN-KY] Announcement of Important Resolutions of the 2026 Shareholders' Meeting

Cheng Hann Biotech held its annual shareholders' meeting on May 26, 2026, approving the 2025 busines… · 2026-05-26

[Ching-Hant-Gen] Participation in Investor Conference Hosted by Yuanta Securities

Ching-Hant-Gen announced its participation in an investor conference hosted by Yuanta Securities on … · 2026-05-22

【Zheng Han-Innovation】Announcement on the completion of the first share buyback

Zheng Han-Innovation announced on May 29, 115, the completion of its first share buyback. The compan… · 2026-05-29

[Zhenghan-Chuang] March 2026 Monthly Revenue: NT$377 Million (YoY +2.5%)

Zhenghan-Chuang announced its monthly revenue for March 2026 reached NT$377 million, marking a 2.5% … · 2026-03-01

[Formosa Bio-Industry] April 2026 Revenue NT$229.17 Million (Year-on-Year +4.4%)

Formosa Bio-Industry announced its April 2026 monthly revenue of NT$229.167 million, a 4.4% increase… · 2026-04-01

Zentiharvest Biotech: Announcement of Board Approval for Q1 2026 Consolidated Financial Report

Zentiharvest Biotech announced that its board of directors approved the Q1 2026 consolidated financi… · 2026-05-05

[CH Biotech] Board Meeting Date Set for Q1 2026 Financial Report

CH Biotech R&D Co., Ltd. announced its board will meet on May 5, 2026, to review the first quarter f… · 2026-04-27

[CH Biotech] Board Meeting Date Set for Q1 2026 Financial Report

CH Biotech R&D Co., Ltd. announced its board will meet on May 5, 2026, to review the first quarter f… · 2026-04-27

[Zhenghan-Chuang] March 2026 Monthly Revenue: NT$377 Million (YoY +2.5%)

Zhenghan-Chuang announced its monthly revenue for March 2026 reached NT$377 million, marking a 2.5% … · 2026-03-01

[AppliedChem-CREATE] February 2026 Revenue: NT$273 Million (YoY +2.1%)

AppliedChem-CREATE released its revenue report for February 2026, recording NT$273 million, a 2.1% i… · 2026-02-01

[Formosa Bio-Industry] April 2026 Revenue NT$229.17 Million (Year-on-Year +4.4%)

Formosa Bio-Industry announced its April 2026 monthly revenue of NT$229.167 million, a 4.4% increase… · 2026-04-01

[CH Biotech] Board Meeting Date Set for Q1 2026 Financial Report

CH Biotech R&D Co., Ltd. announced its board will meet on May 5, 2026, to review the first quarter f… · 2026-04-27

Zentiharvest Biotech: Announcement of Board Approval for Q1 2026 Consolidated Financial Report

Zentiharvest Biotech announced that its board of directors approved the Q1 2026 consolidated financi… · 2026-05-05